• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前驱期帕金森病——以 REM 睡眠行为障碍为窗口。

Prodromal Parkinson's disease--using REM sleep behavior disorder as a window.

机构信息

Department of Neurology, McGill University, Montreal General Hospital, Montreal, Canada.

出版信息

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S1-4. doi: 10.1016/S1353-8020(13)00400-8.

DOI:10.1016/S1353-8020(13)00400-8
PMID:24262156
Abstract

REM sleep behavior disorder (RBD) is characterized by loss of REM atonia of sleep, such that patients act out the contents of their dreams. Perhaps the most important facet of idiopathic RBD is that it is a powerful prodromal marker of Parkinson's disease (PD) and other synucleinopathies. Several prospective studies have now established that patients with idiopathic RBD have up to an 80% risk of developing a defined neurodegenerative synucleinopathy. This has profound implications for understanding and treating early disease. First, the extremely high risk and long latency/time to intervene make RBD patients the ideal candidates for neuroprotective therapy against synucleinopathy. Second, RBD patients can be used as a 'test lab' to assess other potential prodromal predictors of PD, which could be applied to the general population in future large-scale screening programs. Third, assessing epidemiology of RBD allows us to study the epidemiology of PD and dementia with Lewy bodies 10-15 years earlier, reducing bias and opening new hypotheses as to the mechanism of action of selected risk factors. Finally, by prospectively observing RBD patients as they transition to full neurodegenerative synucleinopathy, one has an unprecedented window in which to directly observe evolution of PD from its prodromal stages. The evidence for RBD as a marker of prodromal PD and all these implications will be discussed.

摘要

快速眼动睡眠行为障碍(RBD)的特征是 REM 睡眠时的去弛缓丧失,以至于患者会将梦境内容付诸行动。或许特发性 RBD 最重要的一个方面是,它是帕金森病(PD)和其他突触核蛋白病的一个强有力的前驱标志物。目前已有几项前瞻性研究确立,特发性 RBD 患者有高达 80%的风险发展为明确的神经退行性突触核蛋白病。这对理解和治疗早期疾病具有深远的影响。首先,极高的风险和长潜伏期/干预时间使 RBD 患者成为针对突触核蛋白病的神经保护治疗的理想候选者。其次,RBD 患者可作为“测试实验室”,评估 PD 的其他潜在前驱预测因子,这些预测因子可在未来的大规模筛查计划中应用于一般人群。第三,评估 RBD 的流行病学使我们能够研究 PD 和路易体痴呆的流行病学早 10-15 年,减少偏倚并提出关于选定危险因素作用机制的新假说。最后,通过前瞻性观察 RBD 患者向完全神经退行性突触核蛋白病的转变,人们有了一个前所未有的窗口,可以直接观察 PD 从前驱阶段的演变。将讨论 RBD 作为 PD 前驱标志物的证据以及所有这些影响。

相似文献

1
Prodromal Parkinson's disease--using REM sleep behavior disorder as a window.前驱期帕金森病——以 REM 睡眠行为障碍为窗口。
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S1-4. doi: 10.1016/S1353-8020(13)00400-8.
2
REM sleep behavior disorder: from dreams to neurodegeneration.快速眼动睡眠行为障碍:从梦境到神经退行性变。
Neurobiol Dis. 2012 Jun;46(3):553-8. doi: 10.1016/j.nbd.2011.10.003. Epub 2011 Oct 14.
3
Clinical implication of REM sleep behavior disorder in Parkinson's disease.帕金森病 REM 睡眠行为障碍的临床意义。
J Parkinsons Dis. 2014;4(2):237-44. doi: 10.3233/JPD-130293.
4
Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years.快速眼动睡眠行为障碍作为神经退行性变的生物标志物:过去 10 年。
Sleep Med. 2013 Aug;14(8):763-7. doi: 10.1016/j.sleep.2012.09.001. Epub 2012 Oct 8.
5
[Sleep behavior disorder (RBD) in synucleionopaties].[突触核蛋白病中的睡眠行为障碍(快速眼动睡眠行为障碍)]
Glas Srp Akad Nauka Med. 2009(50):7-15.
6
Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire.使用快速眼动睡眠行为障碍筛查问卷研究帕金森病中的 REM 睡眠无动症。
Mov Disord. 2014 May;29(6):736-42. doi: 10.1002/mds.25832. Epub 2014 Mar 11.
7
Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.验证前驱期帕金森病的 MDS 研究标准:在 REM 睡眠行为障碍 (RBD) 队列中的纵向评估。
Mov Disord. 2017 Jun;32(6):865-873. doi: 10.1002/mds.26989. Epub 2017 Apr 21.
8
Postural sway in idiopathic rapid eye movement sleep behavior disorder: a potential marker of prodromal Parkinson's disease.特发性快速眼动睡眠行为障碍中的姿势性摇摆:帕金森病前驱期的一个潜在标志物。
Brain Res. 2014 Apr 22;1559:26-32. doi: 10.1016/j.brainres.2014.02.040. Epub 2014 Mar 3.
9
Clinical significance of REM sleep behavior disorder in Parkinson's disease.帕金森病 REM 睡眠行为障碍的临床意义。
Sleep Med. 2013 Feb;14(2):131-5. doi: 10.1016/j.sleep.2012.10.011. Epub 2012 Dec 3.
10
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.帕金森病如何开始?特发性 REM 睡眠行为障碍的前驱期帕金森病运动变化。
Brain. 2012 Jun;135(Pt 6):1860-70. doi: 10.1093/brain/aws093. Epub 2012 May 4.

引用本文的文献

1
Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative Review.神经退行性蛋白质病中的医疗复杂性:一篇综述
Healthcare (Basel). 2025 Jul 31;13(15):1873. doi: 10.3390/healthcare13151873.
2
Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder.孤立性快速眼动睡眠行为障碍患者脑胆碱能功能障碍的进展。
Eur J Neurol. 2024 Jan;31(1):e16101. doi: 10.1111/ene.16101. Epub 2023 Oct 17.
3
The Accuracy and Reliability of Sleep Staging and Sleep Biomarkers in Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder.
孤立性快速眼动睡眠行为障碍患者睡眠分期及睡眠生物标志物的准确性和可靠性
Nat Sci Sleep. 2023 May 3;15:323-331. doi: 10.2147/NSS.S396853. eCollection 2023.
4
Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study "FARPRESTO".特发性 REM 睡眠行为障碍中表型转化的预测风险因素:意大利研究“FARPRESTO”。
Neurol Sci. 2022 Dec;43(12):6919-6928. doi: 10.1007/s10072-022-06374-4. Epub 2022 Sep 10.
5
Deep phenotyping for precision medicine in Parkinson's disease.深度表型分析在帕金森病精准医学中的应用。
Dis Model Mech. 2022 Jun 1;15(6). doi: 10.1242/dmm.049376.
6
Relevance of sleep and associated structural changes in GBA1 mouse to human rapid eye movement behavior disorder.GBA1 小鼠的睡眠与相关结构变化与人类快速眼动行为障碍的相关性。
Sci Rep. 2022 May 13;12(1):7973. doi: 10.1038/s41598-022-11516-x.
7
Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment.新发帕金森病伴或不伴认知障碍时胆碱能神经支配的改变
Mov Disord. 2022 Apr;37(4):713-723. doi: 10.1002/mds.28913. Epub 2022 Jan 17.
8
Preventing Parkinson's Disease: An Environmental Agenda.预防帕金森病:环境议程。
J Parkinsons Dis. 2022;12(1):45-68. doi: 10.3233/JPD-212922.
9
Salivary Heme Oxygenase-1: A Potential Biomarker for Central Neurodegeneration.唾液血红素加氧酶-1:一种中枢神经退行性变的潜在生物标志物。
J Cent Nerv Syst Dis. 2021 Jul 7;13:11795735211029114. doi: 10.1177/11795735211029114. eCollection 2021.
10
The Home-Based Sleep Laboratory.家庭睡眠实验室。
J Parkinsons Dis. 2021;11(s1):S71-S76. doi: 10.3233/JPD-202412.